Mitochondrial pharmacogenomics: barcode for antibiotic therapy
21 September 2011
Download Type: Adobe PDF
This article explores the exciting potential of mitochrondrial pharmacogenetics. Ribosomal RNA (rRNA)-targeting drugs inhibit protein synthesis and represent effective antibiotics for the treatment of infectious diseases.
Such a pharmacogenomic approach might help to optimize antibiotic regimens on the basis of the patient’s genetic backgroundand to increase the number of available antibiotics.